ArticleJournal of the American Heart Association2024

Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States.

Odette S Reifsnider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.